RECURRENT PERICARDITIS
Clinical trials for RECURRENT PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PERICARDITIS trials appear
Sign up with your email to follow new studies for RECURRENT PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets debilitating heart lining pain
Disease control Recruiting nowThis study is testing whether an experimental drug called VTX2735 is safe and can help people with recurrent pericarditis, a painful inflammation of the heart's outer lining. About 50 adults with ongoing chest pain from this condition will take the drug for several weeks. Researc…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug aims to stop debilitating chest pain from returning
Disease control Recruiting nowThis trial is testing if a drug called CardiolRx can prevent painful flare-ups of recurrent pericarditis (chest inflammation) in people who are stopping their current strong medication. About 110 adults who have been stable on their current treatment will receive either CardiolRx…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug trial aims to tame painful, recurring heart inflammation
Disease control Recruiting nowThis study is testing a new drug called KPL-387 to see if it can effectively treat and prevent the return of recurrent pericarditis, a painful inflammation of the heart's lining. It will involve about 165 adults who continue to have flare-ups despite standard treatments. The rese…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New drug aims to tame recurring heart inflammation
Disease control Recruiting nowThis study is testing a medication called KPL-387 for people with recurrent pericarditis, a painful inflammation around the heart. The main goal is to see if patients can safely switch from their current treatments to KPL-387 alone and stay free of flare-ups. Researchers will fol…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC